Abhishek Kavati

  • Citations Per Year
Learn More
BACKGROUND Recent research has quantified the national health care resource use (HCRU) and health care expenditure (HCE) burden associated with adult asthma; however, estimates specific to school-aged children are more than 2 decades old. OBJECTIVE To estimate the national HCRU and HCEs attributable to asthma among school-aged children in the United(More)
BACKGROUND Poorly controlled asthma has far-reaching effects on school-age children and their parents, but little is known about the national impact on health-related quality of life (HRQoL). OBJECTIVE To examine HRQoL associated with asthma and indicators of poorly controlled asthma in the United States. METHODS This was a cross-sectional analysis of(More)
OBJECTIVE To assess asthma control and associations with health-related quality of life (HRQoL) and economic outcomes among patients with asthma and allergic comorbidities treated with inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) combination therapy. METHODS Data from the 2011-2013 US National Health and Wellness Survey were used to(More)
BACKGROUND There are limited pediatric data about the use of omalizumab, especially the effectiveness and safety of omalizumab in the real-world management of allergic asthma. OBJECTIVE The objective of this study was to summarize the safety and efficacy of omalizumab in both randomized clinical trials (RCT) used for U.S. Food and Drug Administration(More)
BACKGROUND The degree of asthma control among school-aged children (SAC) nationally is not well understood. OBJECTIVE The objective of this study was to characterize poor control among SAC (aged 6-17 years) in the United States. METHODS This was a retrospective analysis of the 2007-2013 Medical Expenditure Panel Survey. Indicators of poor control(More)
OBJECTIVE Few studies have compared the effectiveness of filgrastim (FIL), pegfilgrastim (PEG), and sargramostim (SAR) to reduce the risk of febrile neutropenia (FN) associated with myelosuppressive chemotherapy (M-CT). Two large commercial database analyses were separately conducted to examine the incidence of neutropenia-related and all-cause(More)
OBJECTIVE To examine treatment patterns, treatment response, and demographic and clinical characteristics of patients with chronic idiopathic urticaria (CIU) newly initiated on omalizumab therapy in real-world practice in the US. METHODS This retrospective observational cohort study used US claims data from the HealthCore Integrated Research Database(More)
OBJECTIVE Randomized controlled trials (RCTs) have established the safety and efficacy of omalizumab on clinical parameters, and have also evaluated its impact on patient-reported outcomes (PROs). The purpose of this systematic literature review was to review published data based on PRO endpoints in order to determine the benefit of omalizumab as add-on(More)
  • 1